Cerebral Amyloid Angiopathy Burden and Cerebral Microbleeds: Pathological Evidence for Distinct Phenotypes.
Alzheimer’s disease
capillaries
cerebral amyloid angiopathy
neuropathology
Journal
Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863
Informations de publication
Date de publication:
2021
2021
Historique:
pubmed:
16
3
2021
medline:
16
9
2021
entrez:
15
3
2021
Statut:
ppublish
Résumé
The relationship between cerebral microbleeds (CMBs) on hemosiderin-sensitive MRI sequences and cerebral amyloid angiopathy (CAA) remains unclear in population-based participants or in individuals with dementia. To determine whether CMBs on antemortem MRI correlate with CAA. We reviewed 54 consecutive participants with antemortem T2*GRE-MRI sequences and subsequent autopsy. CMBs were quantified on MRIs closest to death. Autopsy CAA burden was quantified in each region including leptomeningeal/cortical and capillary CAA. By a clustering approach, we examined the relationship among CAA variables and performed principal component analysis (PCA) for dimension reduction to produce two scores from these 15 interrelated predictors. Hurdle models assessed relationships between principal components and lobar CMBs. MRI-based CMBs appeared in 20/54 (37%). 10 participants had ≥2 lobar-only CMBs. The first two components of the PCA analysis of the CAA variables explained 74% variability. The first rotated component (RPC1) consisted of leptomeningeal and cortical CAA and the second rotated component of capillary CAA (RPC2). Both the leptomeningeal and cortical component and the capillary component correlated with lobar-only CMBs. The capillary CAA component outperformed the leptomeningeal and cortical CAA component in predicting lobar CMBs. Both capillary and the leptomeningeal/cortical components correlated with number of lobar CMBs. Capillary and leptomeningeal/cortical scores correlated with lobar CMBs on MRI but lobar CMBs were more closely associated with the capillary component. The capillary component correlated with APOEɛ4, highlighting lobar CMBs as one aspect of CAA phenotypic diversity. More CMBs also increase the probability of underlying CAA.
Sections du résumé
BACKGROUND
The relationship between cerebral microbleeds (CMBs) on hemosiderin-sensitive MRI sequences and cerebral amyloid angiopathy (CAA) remains unclear in population-based participants or in individuals with dementia.
OBJECTIVE
To determine whether CMBs on antemortem MRI correlate with CAA.
METHODS
We reviewed 54 consecutive participants with antemortem T2*GRE-MRI sequences and subsequent autopsy. CMBs were quantified on MRIs closest to death. Autopsy CAA burden was quantified in each region including leptomeningeal/cortical and capillary CAA. By a clustering approach, we examined the relationship among CAA variables and performed principal component analysis (PCA) for dimension reduction to produce two scores from these 15 interrelated predictors. Hurdle models assessed relationships between principal components and lobar CMBs.
RESULTS
MRI-based CMBs appeared in 20/54 (37%). 10 participants had ≥2 lobar-only CMBs. The first two components of the PCA analysis of the CAA variables explained 74% variability. The first rotated component (RPC1) consisted of leptomeningeal and cortical CAA and the second rotated component of capillary CAA (RPC2). Both the leptomeningeal and cortical component and the capillary component correlated with lobar-only CMBs. The capillary CAA component outperformed the leptomeningeal and cortical CAA component in predicting lobar CMBs. Both capillary and the leptomeningeal/cortical components correlated with number of lobar CMBs.
CONCLUSION
Capillary and leptomeningeal/cortical scores correlated with lobar CMBs on MRI but lobar CMBs were more closely associated with the capillary component. The capillary component correlated with APOEɛ4, highlighting lobar CMBs as one aspect of CAA phenotypic diversity. More CMBs also increase the probability of underlying CAA.
Identifiants
pubmed: 33720897
pii: JAD201536
doi: 10.3233/JAD-201536
pmc: PMC8113155
mid: NIHMS1694280
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
113-122Subventions
Organisme : NIA NIH HHS
ID : R01 AG056366
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG016574
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG011378
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS097495
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG006786
Pays : United States
Organisme : NIA NIH HHS
ID : R37 AG011378
Pays : United States
Organisme : NIA NIH HHS
ID : K76 AG057015
Pays : United States
Références
J Neuropathol Exp Neurol. 2002 Mar;61(3):282-93
pubmed: 11895043
Alzheimers Dement. 2015 Dec;11(12):1480-1488
pubmed: 26079413
Stroke. 2018 Feb;49(2):491-497
pubmed: 29335334
Neurology. 2008 Apr 1;70(14):1208-14
pubmed: 18378884
Neuroepidemiology. 2008;30(1):58-69
pubmed: 18259084
Mayo Clin Proc. 2020 Jun;95(6):1195-1205
pubmed: 32498775
Stroke. 2014 Aug;45(8):2280-5
pubmed: 24947286
Acta Neuropathol. 2010 Mar;119(3):291-302
pubmed: 19937043
AJNR Am J Neuroradiol. 1999 Apr;20(4):637-42
pubmed: 10319975
Neuroimage. 2008 Feb 1;39(3):1186-97
pubmed: 18054253
J Neuropathol Exp Neurol. 2010 Nov;69(11):1158-67
pubmed: 20940625
Lancet Neurol. 2018 Jun;17(6):539-547
pubmed: 29778365
Alzheimers Dement. 2011 Jul;7(4):367-85
pubmed: 21784348
Neurology. 2020 Jan 14;94(2):e190-e199
pubmed: 31801832
J Lipid Res. 1990 Mar;31(3):545-8
pubmed: 2341813
Neurology. 1991 Apr;41(4):479-86
pubmed: 2011243
Neurology. 2015 Mar 24;84(12):1206-12
pubmed: 25716356
Brain. 2017 Jul 1;140(7):1829-1850
pubmed: 28334869
Neurology. 2019 Jan 15;92(3):e253-e262
pubmed: 30568001
Lancet Neurol. 2009 Feb;8(2):165-74
pubmed: 19161908
Am J Neurodegener Dis. 2014 Mar 28;3(1):19-32
pubmed: 24754000
Stroke. 2009 Sep;40(9):3022-7
pubmed: 19556530
JAMA Neurol. 2016 Aug 1;73(8):934-43
pubmed: 27271785
J Stroke Cerebrovasc Dis. 2019 Dec;28(12):104451
pubmed: 31668581
Stroke. 2014 May;45(5):1492-4
pubmed: 24713533
Brain. 2020 Dec 5;143(11):3343-3351
pubmed: 32935842
Neurology. 2001 Feb 27;56(4):537-9
pubmed: 11222803
Stroke. 2017 Dec;48(12):3210-3214
pubmed: 29070715
JAMA Neurol. 2015 May;72(5):539-45
pubmed: 25798556